National Heart Centre

What National Heart Centre does

National Heart Centre Singapore (NHCS), operating as National Heart Centre of Singapore Pte Ltd, is a public specialist cardiac care institution and the national referral centre for cardiovascular disease within the SingHealth cluster, established in 1998 and headquartered at 5 Hospital Drive, Singapore. The institution provides comprehensive tertiary cardiac care spanning prevention, diagnosis, interventional procedures, surgery, rehabilitation, and transplant, serving both adult and congenital heart disease patients. Its clinical portfolio includes multidisciplinary programmes in Heart Failure, Structural Heart Disease, Adult Congenital Heart Disease, Heart Transplant & Mechanical Circulatory Support, ECMO, and the Cardiovascular Ageing and Longevity Programme (CRANE), with technical capabilities extending to first-in-region transcatheter procedures such as TAVI, MitraClip, PASCAL, and TriClip.

NHCS has developed proprietary clinical and AI technology assets, most notably the CARDIA-GM platform, a deep-learning computer-vision system that analyses cardiac MRI scans to detect and quantify scarred heart muscle tissue and microvascular obstruction within 30-60 seconds at 95% accuracy, validated across approximately 3,000 images from over 500 patients. The Functional Coronary Angiography technique uses pressure-sensing guidewires to diagnose coronary microvascular dysfunction and has been used on over 100 patients. The institution is also piloting a workflow-optimisation initiative that has reduced consumable collection trips for nursing staff by 58% and saves 7,400 hours annually.

Commercially, NHCS operates under Singapore's public healthcare financing framework with revenue streams from specialist outpatient clinic services, inpatient ward admissions, interventional procedures, and teleconsultations, supplemented by grants and philanthropic funding such as the $6.5 million Lien Foundation grant for the Heartlanders programme. Its go-to-market relies on specialist referrals, a 194-GP referral network within SingHealth's primary care network, community nurse integration through SingHealth's Office of Regional Health, and partnerships with adjacent institutions such as SGH, KKH, the Singapore Heart Foundation, and Active Ageing Centres. Patient volume signals include nearly 4,000 patients in the Adult Congenital Heart Disease programme and a target cohort of more than 9,000 heart failure patients for Heartlanders over five years.

Name

National Heart Centre

Legal name

National Heart Centre of Singapore Pte Ltd

Website

https://nhcs.com.sg

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

51–100 employees

Short description

National Heart Centre Singapore (NHCS) is Singapore's national specialist cardiac care institution within the SingHealth cluster, delivering tertiary cardiology, cardiothoracic surgery, transplant, and community-based heart failure programmes, and developing proprietary AI diagnostics such as the CARDIA-GM cardiac MRI platform.

Ownership category

akta.pro rank

Product category

Cardiovascular Specialty Hospital

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Ambulatory Health Care Services (621), Diagnostic Imaging Centers (621512)

SIC

Services-Hospitals (8060), Services-Specialty Outpatient Facilities, Nec (8093), Services-Home Health Care Services (8082)

akta.pro primary industry

Cardiovascular / Cath Lab & Electrophysiology Centers (HLAFAIAI)

akta.pro secondary industries

General Cardiology (Consultative) (HLAKABAA), Ambulatory Cardiology Diagnostic & Procedure Centers (Non-hospital-based) (HLAFABAK), Cardiac & Pulmonary Clinical Home Health (e.g., CHF/COPD) (HSABACAI)

Keywords

• Cardiac care services
• Cardiovascular diagnostics
• Heart failure management
• Structural heart disease
• Interventional cardiology

Headquarters

HQ city

Singapore

HQ country

Singapore

HQ region

Asia

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. Specialist Outpatient Clinic Services: Tertiary cardiac care services including consultations, diagnostic tests, and treatments provided through specialist outpatient clinics.
2. Inpatient Ward Services: Hospital admission services including surgical procedures, cardiac care, and intensive care.
3. Cardiac Procedures and Surgery: Revenue from interventional procedures including coronary angioplasty, valve repair/replacement, heart transplant, and mechanical circulatory support.
4. Teleconsultation Services: Remote patient consultations for follow-up care and ongoing monitoring.

Go-to-market motion1 record

Distribution channels6 records

Marketing channels7 records

Core offering

National Heart Centre Singapore (NHCS) provides comprehensive tertiary cardiac care services spanning prevention, diagnosis, treatment, and rehabilitation for cardiovascular diseases. As a national and regional referral centre, it offers specialty outpatient clinics, inpatient ward services, interventional procedures (angioplasty, TAVI, MitraClip), cardiac surgery (CABG, valve repair/replacement, heart transplant), and AI-powered diagnostics through its proprietary CARDIA-GM platform.

Product overview

National Heart Centre Singapore (NHCS) operates as a specialized cardiac care institution within the SingHealth public healthcare cluster, offering a comprehensive portfolio of clinical programmes, diagnostic services, and treatment procedures for cardiovascular conditions. The centre provides both inpatient and outpatient care through specialty programmes including Heart Failure, Structural Heart Disease, Adult Congenital Heart Disease, and Cardiovascular Ageing and Longevity (CRANE). Treatment capabilities span from minimally invasive catheter-based procedures (coronary angioplasty, TAVI, MitraClip) to complex open-heart surgeries (CABG, valve repair/replacement) and heart transplantation. NHCS has developed proprietary AI technology including CARDIA-GM for rapid cardiac MRI analysis and Functional Coronary Angiography for diagnosing microvascular disease. Community care is supported through the Heartlanders programme and Health Buddy mobile application.

Differentiator

Problem solved

Functional benefit

Products and services

• CARDIA-GM AI Platform Artificial intelligence platform that analyzes cardiac MRI scans to detect and quantify heart muscle damage (scarring and microvascular obstruction) in under 60 seconds with 95% accuracy, enabling rapid risk stratification for heart attack patients.
• Functional Coronary Angiography Novel diagnostic technique using pressure-sensing guidewires to detect blood flow and pressure in cardiac capillaries, designed for patients with chest pain symptoms but no arterial blockages visible on standard tests.
• Heart Failure Programme Multidisciplinary programme providing comprehensive heart failure management through structured outpatient care, aiming to prolong survival, improve quality of life, and reduce hospital admissions.
• Structural Heart Disease Programme Leading regional programme treating valvular heart disease and structural heart abnormalities, offering TAVI, MitraClip, PASCAL, TriClip, TriValve, and other transcatheter therapies.
• Heartlanders Programme Heart failure care initiative integrating early palliative support into cardiovascular treatment, partnering with GPs and community nurses to reduce hospital readmissions and improve patient quality of life.
• Cardiovascular Ageing and Longevity Programme (CRANE) Asia Pacific's first comprehensive initiative combining clinical care with research to promote cardiovascular longevity through personalized exercise and nutrition recommendations, regular monitoring, and early intervention.
• Coronary Angioplasty (PCI) Minimally invasive non-surgical procedure using catheter with balloon to open narrowed coronary arteries, often with stent placement to restore blood flow to the heart muscle.
• Valve Repair/Replacement Surgery Surgical procedures to treat diseased heart valves including open-heart surgery and minimally invasive transcatheter techniques (TAVI, MitraClip, TriClip) for valvular heart disease.
• Coronary Artery Bypass Grafting (CABG) Open heart surgery using veins and/or arteries to bypass blocked or narrowed coronary blood vessels, including on-pump and off-pump (beating heart) techniques.
• Heart Transplant & Mechanical Assist Device Programme Advanced programme providing heart transplantation and mechanical circulatory support devices (including LVAD) for patients with end-stage heart failure.
• Extracorporeal Membrane Oxygenation (ECMO) Programme Life support programme providing temporary mechanical circulatory and respiratory support for patients with severe heart or lung failure.
• Adult Congenital Heart Disease Programme Specialized programme providing screening, care, and follow-up services for adults with congenital heart conditions, managing nearly 4,000 patients with multidisciplinary team support.
• Cardiovascular Genetics Service Specialized service providing genetic assessment and counselling for patients and families with diagnosed or suspected inherited cardiac conditions.
• Health Buddy App Mobile application enabling patients to manage appointments, refill medications, and access health services. Available on iOS, Android, and Huawei app platforms.

Quantifiable outcome

• 95% accuracy in cardiac MRI analysis
• +3 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature5 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• Lien Centre for Palliative Care (LCPC) at Duke-NUS Medical SchoolcoreStrategic or Co-development Partner · 20 January 2025Collaborative development of cardio-palliative care course to equip healthcare professionals with skills to deliver generalist palliative care. Course prepares staff and community partners to initiate care conversations and manage complex interventions for heart failure patients.
• General Practitioners Network (194 GPs in Delivering On Target Primary Care Network)coreChannel Partner/ Reseller/ DistributorNetwork of 194 GPs empowered to manage heart failure patients post-discharge, including medication adjustments and liaison with NHCS cardiologists. GPs provide symptom monitoring, health coaching, and timely intervention to prevent hospital readmissions.
• SingHealth Office of Regional Health - Community NursescoreChannel Partner/ Reseller/ DistributorCommunity nurses provide continuous care to heart failure patients post-discharge, including symptom monitoring, personalised health coaching, medication consolidation, and escalation coordination with specialists. Nurses are stationed at Community Health Posts, Active Ageing Centres, and community locations.
• Singapore Heart FoundationminorStrategic or Co-development PartnerPartner for cardiac rehabilitation services, providing community-based rehabilitation programmes for patients transitoned from NHCS inpatient services to support recovery and independence.
• KK Women’s and Children’s Hospital (KKH)coreStrategic or Co-development PartnerMonthly Young Adult Congenital Heart (YACH) transition clinic collaboration with paediatric cardiologists to support seamless transition of congenital heart disease patients from paediatric to adult care services.
• Singapore General Hospital (SGH)coreStrategic or Co-development PartnerJoint Cardiac Obstetric Clinic collaboration for managing cardiac conditions during pregnancy, and Pulmonary Hypertension Clinic collaboration with respiratory and rheumatology specialists.
• Active Ageing Centres (AACs)minorChannel Partner/ Reseller/ DistributorCommunity centres providing social engagement and wellness programmes for heart failure patients to remain socially connected and motivated to manage their health.

Scale indicators10 records

Recent moves7 records

Expansion highlights7 records

Broad incumbents

• Mount Sinai Heart: US-based specialty heart centre within Mount Sinai Health System with strong structural heart, interventional cardiology, and AI-driven imaging research programmes — comparable breadth and academic orientation to NHCS.
• Cleveland Clinic: Global leader in cardiac care with a top-ranked heart institute offering structural heart, transplant, and advanced interventional programmes. Comparable to NHCS in pioneering procedure firsts and clinical-academic integration, though at far larger scale.
• Cedars-Sinai Smidt Heart Institute: Large US specialty heart institute with comprehensive interventional, structural heart, and heart failure programmes including transplant and LVAD. Comparable full-continuum cardiac portfolio and academic-clinical model.

Regional players

• Gleneagles Hospital Singapore: Major private hospital in Singapore offering cardiac catheterisation, interventional cardiology, and cardiac surgery. Comparable private-pay cardiac service line competing for premium Singapore and regional patients.
• Tan Tock Seng Hospital: Large Singapore public hospital under NHG with cardiology and cardiothoracic surgery services. Local comparable for general and tertiary cardiac service provision, though broader than cardiac-specialty focus.
• Asan Medical Center (Heart Institute): One of Asia's largest cardiac centres in Seoul offering structural heart, transplant, and advanced interventional programmes. Closest regional comparable to NHCS in scale and procedure breadth, competing for Southeast Asian referrals.
• Bangkok Heart Hospital: Dedicated cardiac hospital in Thailand's leading medical tourism network. Comparable dedicated heart-specialty model with strong regional patient pull, competing with NHCS for Southeast Asian complex cardiac cases.

Direct peers

• Royal Brompton & Harefield Hospitals: UK specialist heart and lung hospitals known for advanced interventional cardiology, structural heart, and heart failure programmes. Comparable national-level specialty cardiac centre with strong academic ties.
• National University Heart Centre, Singapore (NUHCS): Singapore's other national-level cardiac centre under the National University Health System. Direct competitor for tertiary cardiac referrals, structural heart procedures, and heart transplant cases within the same domestic market.
• Texas Heart Institute: Pioneering cardiac specialty institute historically known for heart transplant, mechanical circulatory support, and structural heart innovation. Comparable positioning as a dedicated heart-specialty research and clinical centre.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xtwitter.com/healthxchange
• YouTubeyoutube.com/NationalHeartCentreSingapore
• Facebookfacebook.com/NationalHeartCentreSingapore
• LinkedInlinkedin.com/company/national-heart-centre-singapore
• Instagraminstagram.com/nhcsconnects

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about National Heart Centre